Matches in SemOpenAlex for { <https://semopenalex.org/work/W2185297282> ?p ?o ?g. }
- W2185297282 endingPage "32074" @default.
- W2185297282 startingPage "32061" @default.
- W2185297282 abstract "TNF-like ligand 1A (TL1A) and its unique receptor death receptor 3 (DR3) acts as broad T-cell costimulator involved in regulatory mechanisms of adaptive immune response under physiological and pathological settings. Moreover, we have recently shown that TL1A negatively regulates B-cell proliferation. Despite increasing interest on the TL1A/DR3-axis functions, very little is known on its expression and role in leukemia. In this study, we investigated the expression and function of TL1A/DR3 axis in chronic lymphocytic leukemia (CLL). DR3 was differentially expressed in activated CLL cells and predominantly detected in patients with early clinical stage disease. Soluble TL1A has been revealed in the sera of CLL patients where higher TL1A levels were associated with early stage disease. T cells, monocytes and leukemic B cells have been identified as major sources of TL1A in CLL. The relevance of these findings has been sustained by functional data showing that exogenous TL1A reduces CLL proliferation induced by stimulation of the B cell receptor. Overall, these data document the expression of the TL1A/DR3 axis in early-stage CLL. They also identify a novel function for TL1A as a negative regulator of leukemic cell proliferation that may influence the CLL physiopathology and clinical outcome at an early-stage disease." @default.
- W2185297282 created "2016-06-24" @default.
- W2185297282 creator A5003274863 @default.
- W2185297282 creator A5003507376 @default.
- W2185297282 creator A5008332699 @default.
- W2185297282 creator A5022596417 @default.
- W2185297282 creator A5032293712 @default.
- W2185297282 creator A5035606506 @default.
- W2185297282 creator A5036223053 @default.
- W2185297282 creator A5037338900 @default.
- W2185297282 creator A5039107924 @default.
- W2185297282 creator A5045665524 @default.
- W2185297282 creator A5048748107 @default.
- W2185297282 creator A5055628496 @default.
- W2185297282 creator A5066461145 @default.
- W2185297282 creator A5083942494 @default.
- W2185297282 creator A5085796975 @default.
- W2185297282 date "2015-09-15" @default.
- W2185297282 modified "2023-10-11" @default.
- W2185297282 title "Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia" @default.
- W2185297282 cites W1531083786 @default.
- W2185297282 cites W1578322024 @default.
- W2185297282 cites W1969452571 @default.
- W2185297282 cites W1969771851 @default.
- W2185297282 cites W1971411560 @default.
- W2185297282 cites W1976088592 @default.
- W2185297282 cites W1977821967 @default.
- W2185297282 cites W1978824927 @default.
- W2185297282 cites W1984999956 @default.
- W2185297282 cites W1988567016 @default.
- W2185297282 cites W1994266361 @default.
- W2185297282 cites W1995871393 @default.
- W2185297282 cites W2003423830 @default.
- W2185297282 cites W2004846994 @default.
- W2185297282 cites W2006563647 @default.
- W2185297282 cites W2006775012 @default.
- W2185297282 cites W2023415425 @default.
- W2185297282 cites W2023418231 @default.
- W2185297282 cites W2024489920 @default.
- W2185297282 cites W2026883661 @default.
- W2185297282 cites W2032553162 @default.
- W2185297282 cites W2038678963 @default.
- W2185297282 cites W2041218985 @default.
- W2185297282 cites W2047504529 @default.
- W2185297282 cites W2054498103 @default.
- W2185297282 cites W2058786179 @default.
- W2185297282 cites W2064930004 @default.
- W2185297282 cites W2065350308 @default.
- W2185297282 cites W2066373927 @default.
- W2185297282 cites W2070869625 @default.
- W2185297282 cites W2087221993 @default.
- W2185297282 cites W2090358449 @default.
- W2185297282 cites W2091664866 @default.
- W2185297282 cites W2095491662 @default.
- W2185297282 cites W2099366837 @default.
- W2185297282 cites W2100690094 @default.
- W2185297282 cites W2120929679 @default.
- W2185297282 cites W2134139148 @default.
- W2185297282 cites W2134276972 @default.
- W2185297282 cites W2135215267 @default.
- W2185297282 cites W2137167164 @default.
- W2185297282 cites W2138749406 @default.
- W2185297282 cites W2138887185 @default.
- W2185297282 cites W2142099365 @default.
- W2185297282 cites W2143790526 @default.
- W2185297282 cites W2161890468 @default.
- W2185297282 cites W2171225843 @default.
- W2185297282 cites W2172019913 @default.
- W2185297282 cites W2318933236 @default.
- W2185297282 cites W2323490326 @default.
- W2185297282 cites W4245949927 @default.
- W2185297282 cites W60865865 @default.
- W2185297282 doi "https://doi.org/10.18632/oncotarget.5201" @default.
- W2185297282 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4741659" @default.
- W2185297282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26393680" @default.
- W2185297282 hasPublicationYear "2015" @default.
- W2185297282 type Work @default.
- W2185297282 sameAs 2185297282 @default.
- W2185297282 citedByCount "11" @default.
- W2185297282 countsByYear W21852972822017 @default.
- W2185297282 countsByYear W21852972822018 @default.
- W2185297282 countsByYear W21852972822019 @default.
- W2185297282 countsByYear W21852972822021 @default.
- W2185297282 countsByYear W21852972822022 @default.
- W2185297282 crossrefType "journal-article" @default.
- W2185297282 hasAuthorship W2185297282A5003274863 @default.
- W2185297282 hasAuthorship W2185297282A5003507376 @default.
- W2185297282 hasAuthorship W2185297282A5008332699 @default.
- W2185297282 hasAuthorship W2185297282A5022596417 @default.
- W2185297282 hasAuthorship W2185297282A5032293712 @default.
- W2185297282 hasAuthorship W2185297282A5035606506 @default.
- W2185297282 hasAuthorship W2185297282A5036223053 @default.
- W2185297282 hasAuthorship W2185297282A5037338900 @default.
- W2185297282 hasAuthorship W2185297282A5039107924 @default.
- W2185297282 hasAuthorship W2185297282A5045665524 @default.
- W2185297282 hasAuthorship W2185297282A5048748107 @default.
- W2185297282 hasAuthorship W2185297282A5055628496 @default.
- W2185297282 hasAuthorship W2185297282A5066461145 @default.